Feb 12, 2025
Samsung Biologics recognized for leadership band in water security
Jan 22, 2025
Samsung Biologics reports fourth quarter and fiscal year 2024 financial results
Jan 14, 2025
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference
Dec 16, 2024
Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index
Dec 03, 2024
Samsung Biologics hosts ESG event with suppliers to strengthen decarbonization efforts
Nov 19, 2024
Samsung Biologics signs manufacturing deal with European pharmaceutical company
Nov 08, 2024
Samsung Biologics earns ISO certifications in recognition of business excellence
Oct 23, 2024
Samsung Biologics reports third quarter 2024 financial results
Oct 21, 2024
Samsung Biologics signs largest manufacturing deal with Asia-based pharmaceutical company
Oct 14, 2024
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
Sep 25, 2024
Samsung Biologics launches development platforms for enhanced therapeutic efficacy
Apr 24, 2024
Samsung Biologics Reports First Quarter 2024 Financial Results
Feb 13, 2024
Samsung Biologics awarded Leadership status by CDP for climate action efforts
Feb 07, 2024
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing
Jan 24, 2024
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2023 Financial Results
Jan 22, 2024
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating
Jan 26, 2021
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA
Dec 16, 2020
Samsung Biologics Names John Rim as President and CEO
Dec 04, 2020
Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch
Nov 18, 2020
Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility